Daymark Wealth Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
+1,945
| New | +$244K | 0.01% | 493 |
|
|
2025
Q1 | – | Sell |
-1,786
| Closed | -$244K | – | 520 |
|
|
2024
Q4 | $244K | Buy |
+1,786
| New | +$244K | 0.01% | 450 |
|
|
2024
Q3 | – | Sell |
-1,774
| Closed | -$244K | – | 523 |
|
|
2024
Q2 | $244K | Buy |
1,774
+274
| +18% | +$37.7K | 0.01% | 444 |
|
|
2024
Q1 | $207K | Buy |
+1,500
| New | +$207K | 0.01% | 412 |
|